Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Incidence of Invasive Fungal Disease on Posaconazole Prophylaxis
2016-001223-31Phase 4Completed
- Sponsor
- King's College Hospital
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of posaconazole in aplastic anemia, myelodysplastic syndrome (MDS), acute myeloid leukemia (AML) and 2 more (3 arms), sponsored by King's College Hospital. Started Sep 2016; status: completed.
02
Drugs
posaconazole
03
Conditions
aplastic anemiamyelodysplastic syndrome (MDS)acute myeloid leukemia (AML)refractory anemia with excess blasts in transformation (RAEB-T)invasive mycoses
Beyond the preview
Go deeper on 2016-001223-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001223-31.